LAMISIL AT Drug Patent Profile
✉ Email this page to a colleague
When do Lamisil At patents expire, and what generic alternatives are available?
Lamisil At is a drug marketed by Karo Hlthcare and is included in two NDAs.
The generic ingredient in LAMISIL AT is terbinafine hydrochloride. There are twenty-seven drug master file entries for this compound. Forty-five suppliers are listed for this compound. Additional details are available on the terbinafine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Lamisil At
A generic version of LAMISIL AT was approved as terbinafine hydrochloride by TARO on July 2nd, 2007.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LAMISIL AT?
- What are the global sales for LAMISIL AT?
- What is Average Wholesale Price for LAMISIL AT?
Summary for LAMISIL AT
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 91 |
Clinical Trials: | 19 |
Patent Applications: | 4,477 |
Drug Prices: | Drug price information for LAMISIL AT |
DailyMed Link: | LAMISIL AT at DailyMed |
Recent Clinical Trials for LAMISIL AT
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Oregon Health and Science University | Early Phase 1 |
The Malassezia Foundation | Early Phase 1 |
Pak Emirates Military Hospital | Phase 3 |
US Patents and Regulatory Information for LAMISIL AT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Karo Hlthcare | LAMISIL AT | terbinafine | GEL;TOPICAL | 021958-001 | Jul 24, 2006 | OTC | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Karo Hlthcare | LAMISIL AT | terbinafine hydrochloride | SOLUTION;TOPICAL | 021124-001 | Mar 17, 2000 | OTC | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Karo Hlthcare | LAMISIL AT | terbinafine hydrochloride | SPRAY;TOPICAL | 021124-002 | Mar 17, 2000 | OTC | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for LAMISIL AT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Karo Hlthcare | LAMISIL AT | terbinafine | GEL;TOPICAL | 021958-001 | Jul 24, 2006 | ⤷ Sign Up | ⤷ Sign Up |
Karo Hlthcare | LAMISIL AT | terbinafine hydrochloride | SOLUTION;TOPICAL | 021124-001 | Mar 17, 2000 | ⤷ Sign Up | ⤷ Sign Up |
Karo Hlthcare | LAMISIL AT | terbinafine hydrochloride | SOLUTION;TOPICAL | 021124-001 | Mar 17, 2000 | ⤷ Sign Up | ⤷ Sign Up |
Karo Hlthcare | LAMISIL AT | terbinafine hydrochloride | SPRAY;TOPICAL | 021124-002 | Mar 17, 2000 | ⤷ Sign Up | ⤷ Sign Up |
Karo Hlthcare | LAMISIL AT | terbinafine hydrochloride | SOLUTION;TOPICAL | 021124-001 | Mar 17, 2000 | ⤷ Sign Up | ⤷ Sign Up |
Karo Hlthcare | LAMISIL AT | terbinafine hydrochloride | SPRAY;TOPICAL | 021124-002 | Mar 17, 2000 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for LAMISIL AT
See the table below for patents covering LAMISIL AT around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
South Africa | 8005185 | ⤷ Sign Up | |
South Africa | 7804706 | ⤷ Sign Up | |
Denmark | 153470 | ⤷ Sign Up | |
Czech Republic | 283019 | Topická farmaceutická kompozice, způsob její přípravy a způsob léčení fungálních infekcí (TOPIC PHARMACEUTICAL COMPOSITION) | ⤷ Sign Up |
Austria | A602578 | ⤷ Sign Up | |
Italy | 1260710 | COMPOSIZIONI FARMACEUTICHE CONTENENTI UN COMPOSTO ALLILAMMINICO QUALE PRINCIPIO ATTIVO. | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for LAMISIL AT
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0024587 | SPC/GB93/096 | United Kingdom | ⤷ Sign Up | SPC/GB93/096, EXPIRES: 20050805 |
0024587 | 93C0136 | Belgium | ⤷ Sign Up | PRODUCT NAME: TERBINAFINE (250 MG) SOUS FORME DE CHLORHYDRATE (281,25 MG); NAT. REG.: 616 S 201 F3 19911031; FIRST REG.: GB PL 0101/0304 19901003 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |